Nephros (NEPH) Free Cash Flow Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Nephros | 38.93 Mn | 34.91 Mn | 2.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -84.58% |
| Dec 31, 2025 | 16.23% |
| Sep 30, 2025 | 15.48% |
| Jun 30, 2025 | 20.85% |
| Mar 31, 2025 | 16.81% |
| Dec 31, 2024 | 29.07% |
| Sep 30, 2024 | -0.29% |
| Jun 30, 2024 | 17.73% |
| Mar 31, 2024 | 0.73% |
| Dec 31, 2023 | 14.80% |
| Sep 30, 2023 | 20.12% |
| Jun 30, 2023 | 16.74% |
| Mar 31, 2023 | 19.26% |
| Dec 31, 2022 | -16.09% |
| Sep 30, 2022 | 24.93% |
| Jun 30, 2022 | -18.68% |
| Mar 31, 2022 | -22.68% |
| Dec 31, 2021 | 8.70% |
| Sep 30, 2021 | -3.03% |
| Jun 30, 2021 | 16.37% |
| Mar 31, 2021 | 32.29% |
| Dec 31, 2020 | -4.24% |
| Sep 30, 2020 | -10.24% |
| Jun 30, 2020 | -26.36% |
| Mar 31, 2020 | -14.94% |
| Dec 31, 2019 | 19.51% |
| Sep 30, 2019 | 5.08% |
| Jun 30, 2019 | -40.24% |
| Mar 31, 2019 | -2.30% |
| Dec 31, 2018 | 9.85% |
| Sep 30, 2018 | -52.06% |
| Jun 30, 2018 | 3.79% |
| Mar 31, 2018 | 6.36% |
| Dec 31, 2017 | 42.66% |
| Sep 30, 2017 | 0.11% |
| Jun 30, 2017 | 8.94% |
| Mar 31, 2017 | -28.84% |
| Dec 31, 2016 | 3.07% |
| Sep 30, 2016 | -31.58% |
| Jun 30, 2016 | 11.94% |
| Mar 31, 2016 | 0.00% |
| Dec 31, 2015 | -12.93% |
| Sep 30, 2015 | -74.99% |